miércoles, 8 de febrero de 2017

2nd Multi-Stakeholder Symposium on Improving Patient Access to Rare Disease Therapies

2nd Multi-Stakeholder Symposium on Improving Patient Access to Rare Disease Therapies

Eurordis, Rare Diseases Europe



The Voice of Rare Disease
Patients in Europe



2nd Multi-Stakeholder Symposium on Improving Patient Access to Rare Disease Therapies






22 - 23 February 2017. Hotel Le Plaza, Brussels, Belgium

 

Would you like to be a part of a truly multi-stakeholder process aiming to establish sustainable and long-lasting solutions to improve patients’ access to rare disease therapies?


This Symposium on improving patient access to rare disease therapies will bring together patient advocates, payers, HTA bodies, academics, clinicians, policy makers, investors and industry representatives. It will enable participants to understand the interests and challenges of each stakeholder group, to discuss current and emerging initiatives and to continue to work together to improve patients’ access to rare disease therapies.
There are limited places available for this Symposium, please register via the form below.
See the advanced programme and more information (venue, travel & accommodation, programme committee and official partners).
All patient representatives will have their fee waived for this event. Payer bodies, HTA agencies, national competent authorities, regulators or government workers should contact emilie.zingg@eurordis.org to register for this event.
If you have registered for this event and are interested in taking part in the preparatory webinar, on 13 February, kindly contact Eva Bearryman: eva.bearryman@eurordis.org
Please note that the language of this event is English.
Register here:

No hay comentarios:

Publicar un comentario